Pistoia Alliance is a global, not-for-profit members’ organization working to lower barriers to innovation in life science and healthcare R&D. The Pistoia Alliance brings together more than 100 member companies from life science companies, technology and service providers, publishers, and academic groups to transform R&D through pre-competitive collaboration.
Together, we overcome common R&D obstacles by identifying root causes, developing standards and best practices, sharing pre-competitive data and knowledge, and executing technology pilots. From AI to chemical safety to data standards, members collaborate on projects of significant value for the worldwide life sciences R&D community, using The Pistoia Alliance’s framework for open innovation.
The SiLA Consortium is non-profit. It gathers life science experts and mobilizes the industry while developing free & open system communication and data standards to connect scientists with the data that matters.
SiLA and its members provide a framework for the exchange, integration, sharing, and retrieval of electronic laboratory information. These standards define how information is transported from one system to another. Setting the language, structure and data types required for seamless integration, SiLA supports the management, delivery, and evaluation of laboratory services. SiLA is recognized as most commonly used in the world.
Lab Automation Network is an alliance of technologically leading lab automation companies, who have brought together their expertise in laboratory technologies as well as in robotics and digitization.This enables us to deliver technologically advanced laboratory automation solutions spanning the entire value chains for R&D and QC in pharmaceutical, biotech, and chemical industry.
Take advantage of direct access to technology leaders and benefit from our many years of experience in numerous small, medium, and large-scale projects.
Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners. With an international network of life science trade media contacts and a strong technical understanding, Zyme’s experienced team is committed to providing real value from objective-led communications.